These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 16029067)

  • 1. Pharmacokinetic and pharmacodynamic properties of inhaled beclometasone dipropionate delivered via hydrofluoroalkane-containing devices.
    Derom E; Pauwels RA
    Clin Pharmacokinet; 2005; 44(8):815-36. PubMed ID: 16029067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluating the pharmacokinetics of beclometasone dipropionate/formoterol fumarate/glycopyrronium bromide delivered via pressurised metered-dose inhaler using a low global warming potential propellant.
    Rony F; Cortellini M; Guasconi A; Mathews KS; Piccinno A; Poli G; Vanhoutte F; Klein J
    Pulm Pharmacol Ther; 2024 Jun; 85():102299. PubMed ID: 38663512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulite technology: pharmacodynamic and pharmacokinetic implications.
    Woodcock A; Acerbi D; Poli G
    Respir Med; 2002 Aug; 96 Suppl D():S9-15. PubMed ID: 12201080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The efficacy and safety of QVAR (hydrofluoroalkane-beclometasone diproprionate extrafine aerosol) in asthma (Part 2): Clinical experience in children.
    van Schayck CP; Donnell D
    Int J Clin Pract; 2004 Aug; 58(8):786-94. PubMed ID: 15372852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety overview of a new inhaled corticosteroid, QVAR (hydrofluoroalkane-beclomethasone extrafine inhalation aerosol), in asthma.
    Vanden Burgt JA; Busse WW; Martin RJ; Szefler SJ; Donnell D
    J Allergy Clin Immunol; 2000 Dec; 106(6):1209-26. PubMed ID: 11112914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Asthma control with extrafine-particle hydrofluoroalkane-beclometasone vs. large-particle chlorofluorocarbon-beclometasone: a real-world observational study.
    Barnes N; Price D; Colice G; Chisholm A; Dorinsky P; Hillyer EV; Burden A; Lee AJ; Martin RJ; Roche N; von Ziegenweidt J; Israel E
    Clin Exp Allergy; 2011 Nov; 41(11):1521-32. PubMed ID: 21752116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical studies in asthmatics with a new non-extra fine HFA formulation of beclometasone dipropionate (BDP Modulite).
    Bousquet J; Cantini L
    Respir Med; 2002 Aug; 96 Suppl D():S17-27. PubMed ID: 12201078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioavailability of Beclometasone From Two HFA-BDP Formulations With a Spacer.
    Said AS; AbuRuz S; Chrystyn H
    Respir Care; 2019 Oct; 64(10):1222-1230. PubMed ID: 31138731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Switching to CFC-free beclometasone for asthma.
    Drug Ther Bull; 2008 Jun; 46(6):46-8. PubMed ID: 18525059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of HFA- and CFC-beclomethasone dipropionate on the bronchial response to methacholine (MCh) in mild asthma.
    Micheletto C; Guerriero M; Tognella S; Dal Negro RW
    Respir Med; 2005 Jul; 99(7):850-5. PubMed ID: 15939246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Respiratory Tract Deposition of HFA-Beclomethasone and HFA-Fluticasone in Asthmatic Patients.
    Leach CL; Kuehl PJ; Chand R; McDonald JD
    J Aerosol Med Pulm Drug Deliv; 2016 Apr; 29(2):127-33. PubMed ID: 26061801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of respiratory deposition of fluticasone-salmeterol hydrofluoroalkane-134a and hydrofluoroalkane-134a beclomethasone in asthmatic patients.
    Leach CL; Kuehl PJ; Chand R; Ketai L; Norenberg JP; McDonald JD
    Ann Allergy Asthma Immunol; 2012 Mar; 108(3):195-200. PubMed ID: 22374204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution of technetium-99m-labelled QVAR delivered using an Autohaler device in children.
    Devadason SG; Huang T; Walker S; Troedson R; Le Souëf PN
    Eur Respir J; 2003 Jun; 21(6):1007-11. PubMed ID: 12797496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of once or twice daily inhalation of extrafine HFA beclomethasone dipropionate in patients with mild to moderate asthma.
    Gillissen A; Richter A; Oster H; Criée CP
    J Physiol Pharmacol; 2007 Nov; 58 Suppl 5(Pt 1):233-41. PubMed ID: 18204133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects on lung function, symptoms, and bronchial hyperreactivity of low-dose inhaled beclomethasone dipropionate given with HFA-134a or CFC propellant.
    Woodcock A; Williams A; Batty L; Masterson C; Rossetti A; Cantini L
    J Aerosol Med; 2002; 15(4):407-14. PubMed ID: 12581507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of mometasone furoate dry powder inhaler and beclomethasone dipropionate hydrofluoroalkane and chlorofluorocarbon on the hypothalamic-pituitary-adrenal axis in asthmatic subjects.
    Chrousos GP; Ghaly L; Shedden A; Iezzoni DG; Harris AG
    Chest; 2005 Jul; 128(1):70-7. PubMed ID: 16002918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of 2 extrafine hydrofluoroalkane-134a-beclomethasone formulations on methacholine hyperresponsiveness.
    Fardon TC; Burns P; Barnes ML; Lipworth BJ
    Ann Allergy Asthma Immunol; 2006 Mar; 96(3):422-30. PubMed ID: 16597076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Real-life comparison of beclometasone dipropionate as an extrafine- or larger-particle formulation for asthma.
    Price D; Thomas M; Haughney J; Lewis RA; Burden A; von Ziegenweidt J; Chisholm A; Hillyer EV; Corrigan CJ
    Respir Med; 2013 Jul; 107(7):987-1000. PubMed ID: 23643486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The efficacy and safety of QVAR (hydrofluoroalkane-beclometasone diproprionate extrafine aerosol) in asthma (part 1): an update of clinical experience in adults.
    Van Schayck CP; Donnell D
    Int J Clin Pract; 2004 Jul; 58(7):678-88. PubMed ID: 15311725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Equivalence of hydrofluoroalkane (HFA) and chlorofluorocarbons (CFC) formulations of inhaled beclomethasone.
    Lipworth BJ; Jackson CM
    Respir Med; 2000 Feb; 94(2):177; author reply 179-80. PubMed ID: 10714427
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.